Financials
- Market Capitalization 487.13 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.4
Rapporto prezzo/fatturato
3.2
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2852 | ALT Altimmune, Inc. - Common Stock | 2.56 USD | -1.92% | -5.19% | -21.71% | -34.69% | 497.97 M USD | ||
| 2870 | NGNE Neurogene Inc. - Common Stock | 24.44 USD | -7.42% | -8.22% | -31.96% | -16.93% | 489.08 M USD | ||
| 2881 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.40 USD | -4.11% | -6.67% | -21.79% | +13.82% | 483.69 M USD | ||
| 2890 | RZLT Rezolute, Inc. - Common Stock | 4.87 USD | 0.00% | +4.96% | +16.51% | -37.96% | 471.04 M USD |